Yohimbe Bark Liquid Extract, standardized, 2 fl. oz.
|
Yohimbe Bark Liquid Extract, standardized, 2 fl. oz. |
|
|
UN227 $8.25 The alkaloid yohimbe is the main chemical in the yohimbe’s bark. Yohimbe is said to prevent various depressive disorders as it inhibits monoamine oxidase (MAO) and dilates blood vessels. Yohimbe also stops alpha-2 adrenergic receptors that belong to the sympathetic nervous system. Research shows it is a vasodilator, which means that it increases blood flow to the extremities and appendages. In other words, it can treat male impotence, as well as increase the sex drive (libido) in men and in women. In addition , yohimbe has also been shown to help prevent arteries from becoming blocked or clogged and causing myocardial dysfunction or strokes. Not only does yohimbe help men with sexual performance, increase libido, and help prevent heart attacks, but yohimbe also has been shown to decrease fat synthesis in the body by increasing fatty acid mobilization. Used for centuries in West Africa, yohimbe bark was used as a tea to enhance virility. For more than 50 years, before the advent of Viagra, an extract of yohimbe bark, with its active ingredient yohimbine, was used in the United States to treat sexual problems in both males and females. Some human trials have shown that yohimbine provides benefits if there is no organic cause of erectile dysfunction. That is, if the decrease in libido is a result of stress, anxiety, or advancing years, and not due to any illnesses, including psychiatric conditions. The latest German study published in 1997 shows that 71% of 83 males diagnosed with erectile dysfunction responded favorably to yohimbine treatment over an eight-week period. More importantly, it should be noted that yohimbe bark extract does not require testosterone as an aid to enhance libido. Yohimbe Bark Liquid Extract is designed to shorten the time it takes the body to feel the desired effect. Quick-acting sublingual Yohimbe bypasses the digestive system, leaving more active ingredient intact for use by the body.
SELECTED REFERENCES 1. Riley, A., "Yohimbine in the Treatment of Erectile Dysfunction," Br. J. Clin. Pract.: 48, 133, 1994 2. Smith et al., "Alpha 2-Adrenorecptor Antagonists and Male Sexual Behavior: I Mating Behavior," Physiol. Behav. 41, 15, 1987 3. Smith et al., "Alpha 2-Adrenoreceptor Antagonists and Male Sexual Behavior: II Erectile and Ejaculatory Reflexes," Physiol. Behav.: 41, 7, 1987 4. Clark et al., "Testosterone is Not Required for the Enhancement of Sexual Motivation by Yohimbine," Physiol. Behav.: 35, 517, 1985 5. Clark et al., "Enhancement of Sexual Motivation in male Rats by Yohimbimne," Science: 225, 847, 1984 6. Smith, E. & Davidson, J., "Yohimbine Attenuates Aging-Induced Sexual Deficiencies in Male Rats," Physiol. Behav.: 47, 631, 1990 7. Reid et al., "Double-Blind Trial of Yohimbine in Treatment of Psychogenic Impotence," Lancet: 2, 421, 1987 8. Morales et al., "Is Yohimbine Effective in the Treatment of Organic Impotence? Results of a Controlled Trial," J. Urol.: 137, 1168, 1987 9. Vigt et al., "Double-Blind, Placebo-Controlled Safety and Efficacy Trial with Yohimbine Hydrochloride in the Treatment of Nonorganic Erectile Dysfunction," Int. J. Impot. Res.: 9, 155, 1997 10. Morganthaler, J. & Joy, D., Better Sex Through Chemistry, Petaluma, California: Smart Publications, 1994 11. Teloken et al., "Therapeutic Effects of High Dose Yohimbine Hydrochloride in Organic Erectile Dysfunction," J. Urol.: 159, 122, 1998 FREQUENTLY ASKED QUESTIONS 1. What is the optimal use for yohimbine? 2. Does yohimbine have adverse effects? 3. Who should not take yohimbine?
Directions: As a dietary supplement, place 1 dropper under the tongue 1 to 2 times daily. Do not exceed recommended dosage. Warning: These products are not intended to diagnose, treat, cure or prevent any disease. Please consult with a healthcare professional before starting any diet or exercise program. Some of these products are not recommended for individuals under the age of 18. | ||||||||||||||||||||||||
|
This page was last modified on Friday December 30, 2011 |
